Douglas W. Zochodne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Douglas W. Zochodne has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
Ambika Chandrasekhar
Division of Neurology, Department of Medicine, Neuroscience and Mental Health Institute University of Alberta Edmonton Alberta Canada
11 shared publicationsAparna Areti
Neuroscience and Mental Health Institute and Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada
10 shared publications- Anand Krishnan
College of Medicine, University of Saskatchewan
8 shared publications Prashanth Komirishetty
Neuroscience and Mental Health Institute and Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada
8 shared publicationsChu Cheng
Department of Clinical Neurosciences, University of Calgary, Calgary, Canada
7 shared publicationsJose A. Martinez
Formerly of Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
6 shared publications
Latest Publications
- 4 September 2026
- Published by Elsevier
- Vol. 190, 55-73
Roadmap update: Sensory neurodegeneration in diabetes
- 4 September 2026
- Published by Elsevier
- Vol. 190, 55-73
Roadmap update: Sensory neurodegeneration in diabetes
- Open Access
- 23 July 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1899469
Mechanisms, translational opportunities for diabetic polyneuropathy
Diabetic polyneuropathy (DPN) is a common complication of types 1 and 2 diabetes mellitus (DM). Peripheral sensory axons are early and primary targets of DPN, rendering sensory loss, pain and impaired quality of life. While several metabolic and other abnormalities, including abnormal insulin signaling and mitochondrial dysfunction contribute toward DPN, effective therapy to reverse or arrest the disorder is not currently available. DPN is a degenerative condition that involves retraction of distal sensory terminals and failure of regenerative repair. This review summarizes current mechanisms of DPN and potential new approaches that may offer translational opportunities for treatment. Many of these targets have yet to be explored in multiple DM models/paradigms and have not yet entered clinical trials. Nonetheless, specific regeneration pathways may offer a future role to encourage sensory axon resilience and regrowth.
- 23 July 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1899469
Open AccessMechanisms, translational opportunities for diabetic polyneuropathy
Diabetic polyneuropathy (DPN) is a common complication of types 1 and 2 diabetes mellitus (DM). Peripheral sensory axons are early and primary targets of DPN, rendering sensory loss, pain and impaired quality of life. While several metabolic and other abnormalities, including abnormal insulin signaling and mitochondrial dysfunction contribute toward DPN, effective therapy to reverse or arrest the disorder is not currently available. DPN is a degenerative condition that involves retraction of distal sensory terminals and failure of regenerative repair. This review summarizes current mechanisms of DPN and potential new approaches that may offer translational opportunities for treatment. Many of these targets have yet to be explored in multiple DM models/paradigms and have not yet entered clinical trials. Nonetheless, specific regeneration pathways may offer a future role to encourage sensory axon resilience and regrowth.
- 25 May 2026
- Published by Elsevier in Experimental Neurology
- Vol. 404, 115844
Unwanted axon growth: PTEN and the suppression of axon plasticity in adult nerves
- 25 May 2026
- Published by Elsevier in Experimental Neurology
- Vol. 404, 115844
Unwanted axon growth: PTEN and the suppression of axon plasticity in adult nerves
- Open Access
- 8 January 2026
- Published by Wiley in Annals of Neurology
- Vol. 99 (5) , 1251-1262
Conditioning Electrical Stimulation for Patients with Moderate or Severe Carpal Tunnel Syndrome: Double Blinded Randomized Controlled Trial
Objective: Carpal tunnel syndrome (CTS) can drastically impair one's ability to work and interferes with activities of daily living. We recently demonstrated that, in rodents, conditioning electrical stimulation (CES) delivered to the nerve 7 days prior to surgery imparts a conditioning lesion‐like effect by accelerating the rate of regeneration along the entire length of the nerve. The goal of this study is to test the hypothesis that CES could accelerate nerve regeneration and improve function in patients with moderate or severe CTS. Methods: Using a double‐blind randomized controlled study design, patients received surgery + CES or surgery + sham stimulation. They were evaluated at regular intervals for 12 months following intervention. Primary outcome was motor unit number estimation (MUNE), supplemented with secondary outcomes including motor and sensory nerve conduction studies, Semmes Weinstein Monofilaments, and Moberg Pick‐Up Test. Results: Sixty‐four participants were randomized to either the treatment or control groups. There was no significant demographic or physiological difference at baseline between the groups. No major adverse event was found with treatment. Following intervention, there was significantly greater increase in MUNE of 62 ± 71 in the treatment group compared to 25 ± 66 in the controls after 12 months. In the treatment group, there was correspondingly better physiological and functional recovery and hand dexterity compared with the controls. Interpretation: CES is a safe, feasible, and efficacious treatment to improve nerve reinnervation and functional outcomes in patients with moderate or severe CTS. This may open future possibilities for more effective treatment for other peripheral nerve injuries. ANN NEUROL 2026;99:1251–1262
- 8 January 2026
- Published by Wiley in Annals of Neurology
- Vol. 99 (5) , 1251-1262
Open AccessConditioning Electrical Stimulation for Patients with Moderate or Severe Carpal Tunnel Syndrome: Double Blinded Randomized Controlled Trial
Objective: Carpal tunnel syndrome (CTS) can drastically impair one's ability to work and interferes with activities of daily living. We recently demonstrated that, in rodents, conditioning electrical stimulation (CES) delivered to the nerve 7 days prior to surgery imparts a conditioning lesion‐like effect by accelerating the rate of regeneration along the entire length of the nerve. The goal of this study is to test the hypothesis that CES could accelerate nerve regeneration and improve function in patients with moderate or severe CTS. Methods: Using a double‐blind randomized controlled study design, patients received surgery + CES or surgery + sham stimulation. They were evaluated at regular intervals for 12 months following intervention. Primary outcome was motor unit number estimation (MUNE), supplemented with secondary outcomes including motor and sensory nerve conduction studies, Semmes Weinstein Monofilaments, and Moberg Pick‐Up Test. Results: Sixty‐four participants were randomized to either the treatment or control groups. There was no significant demographic or physiological difference at baseline between the groups. No major adverse event was found with treatment. Following intervention, there was significantly greater increase in MUNE of 62 ± 71 in the treatment group compared to 25 ± 66 in the controls after 12 months. In the treatment group, there was correspondingly better physiological and functional recovery and hand dexterity compared with the controls. Interpretation: CES is a safe, feasible, and efficacious treatment to improve nerve reinnervation and functional outcomes in patients with moderate or severe CTS. This may open future possibilities for more effective treatment for other peripheral nerve injuries. ANN NEUROL 2026;99:1251–1262
- Open Access
- 24 October 2025
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 53 (2) , 161-162
In Memoriam, Dr. Keith Brownell (May 7, 1941–March 28, 2025)
- 24 October 2025
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 53 (2) , 161-162
Open AccessIn Memoriam, Dr. Keith Brownell (May 7, 1941–March 28, 2025)
- 16 July 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 476, 123626
Reversible rituximab demyelination in anti-MAG polyneuropathy: A role for IVIG?
- 16 July 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 476, 123626
Reversible rituximab demyelination in anti-MAG polyneuropathy: A role for IVIG?
- Open Access
- 26 February 2025
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 53 (1) , 137-138
Occam’s Razor Revisited: Myasthenia Gravis and Thyroid Ophthalmopathy
- 26 February 2025
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 53 (1) , 137-138
Open AccessOccam’s Razor Revisited: Myasthenia Gravis and Thyroid Ophthalmopathy
- 21 June 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (1) , 786-805
Collaborative Roles for RAC1, ERM Proteins and PTEN During Adult Sensory Axon Regeneration
The role of local of growth cone (GC) manipulation in adult regenerative systems is largely unexplored despite substantial translational importance. Here we investigated collaboration among Rac1 GTPase, its partnering ERM proteins and PTEN in adult sensory neurons and adult nerve regeneration. We confirmed expression of both Rac1 and ERM in adults and noted substantial impacts on neurite outgrowth in naïve and pre-injured adult sensory neurons. PTEN inhibition added to this outgrowth. Rac1 activation acted directly on adult GCs facilitating both attractive turning and advancement. In vivo regeneration indices including electrophysiological recovery, return of sensation, walking, repopulation of myelinated axons and reinnervation of the target epidermis indicated benefits of local Rac1 activation. These indices suggested maximal GC activation whereas local PTEN inhibition offered only limited added improvement. Our findings provide support for the concept of manipulating adult GCs, by emphasizing local Rac1 activation in directing therapy for nerve repair.
- 21 June 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (1) , 786-805
Collaborative Roles for RAC1, ERM Proteins and PTEN During Adult Sensory Axon Regeneration
The role of local of growth cone (GC) manipulation in adult regenerative systems is largely unexplored despite substantial translational importance. Here we investigated collaboration among Rac1 GTPase, its partnering ERM proteins and PTEN in adult sensory neurons and adult nerve regeneration. We confirmed expression of both Rac1 and ERM in adults and noted substantial impacts on neurite outgrowth in naïve and pre-injured adult sensory neurons. PTEN inhibition added to this outgrowth. Rac1 activation acted directly on adult GCs facilitating both attractive turning and advancement. In vivo regeneration indices including electrophysiological recovery, return of sensation, walking, repopulation of myelinated axons and reinnervation of the target epidermis indicated benefits of local Rac1 activation. These indices suggested maximal GC activation whereas local PTEN inhibition offered only limited added improvement. Our findings provide support for the concept of manipulating adult GCs, by emphasizing local Rac1 activation in directing therapy for nerve repair.
- 31 May 2024
- Published by Wiley in Annals of Neurology
- Vol. 96 (2) , 216-230
Manipulation of the Myc Interactome to Enhance Nerve Regeneration in a Murine Model
ObjectiveThis study was undertaken to explore manipulation of the Myc protein interactome, members of an oncogene group, in enhancing the intrinsic growth of injured peripheral adult postmitotic neurons and the nerves they supply. New approaches to enhance adult neuron growth properties are a key strategy in improving nerve regeneration.MethodsExpression and impact of Myc interactome members c-Myc, N-Myc, Mad1, and Max were evaluated within naive and "preconditioned" adult sensory neurons and Schwann cells (SCs), using siRNA and transfection of CRISPR/Cas9 or luciferase reporter in vitro. Morphological, behavioral, and electrophysiological indices of nerve regeneration were analyzed in vivo.Resultsc-Myc, N-Myc, Max, and Mad were expressed in adult sensory neurons and in partnering SCs. In vitro knockdown (KD) of either Mad1 or Max, competitive inhibitors of Myc, unleashed heightened neurite outgrowth in both naive uninjured or preconditioned adult neurons. In contrast, KD or inhibition of both isoforms of Myc was required to suppress growth. In SCs, Mad1 KD not only enhanced migratory behavior but also conditioned increased outgrowth in separately cultured adult sensory neurons. In vivo, local Mad1 KD improved electrophysiological, behavioral, and structural indices of nerve regeneration out to 60 days of follow-up.InterpretationMembers of the Myc interactome, specifically Mad1, are novel targets for improving nerve regeneration. Unleashing of Myc growth signaling through Mad1 KD enhances the regrowth of both peripheral neurons and SCs to facilitate better regrowth of nerves. ANN NEUROL 2024
- 31 May 2024
- Published by Wiley in Annals of Neurology
- Vol. 96 (2) , 216-230
Manipulation of the Myc Interactome to Enhance Nerve Regeneration in a Murine Model
ObjectiveThis study was undertaken to explore manipulation of the Myc protein interactome, members of an oncogene group, in enhancing the intrinsic growth of injured peripheral adult postmitotic neurons and the nerves they supply. New approaches to enhance adult neuron growth properties are a key strategy in improving nerve regeneration.MethodsExpression and impact of Myc interactome members c-Myc, N-Myc, Mad1, and Max were evaluated within naive and "preconditioned" adult sensory neurons and Schwann cells (SCs), using siRNA and transfection of CRISPR/Cas9 or luciferase reporter in vitro. Morphological, behavioral, and electrophysiological indices of nerve regeneration were analyzed in vivo.Resultsc-Myc, N-Myc, Max, and Mad were expressed in adult sensory neurons and in partnering SCs. In vitro knockdown (KD) of either Mad1 or Max, competitive inhibitors of Myc, unleashed heightened neurite outgrowth in both naive uninjured or preconditioned adult neurons. In contrast, KD or inhibition of both isoforms of Myc was required to suppress growth. In SCs, Mad1 KD not only enhanced migratory behavior but also conditioned increased outgrowth in separately cultured adult sensory neurons. In vivo, local Mad1 KD improved electrophysiological, behavioral, and structural indices of nerve regeneration out to 60 days of follow-up.InterpretationMembers of the Myc interactome, specifically Mad1, are novel targets for improving nerve regeneration. Unleashing of Myc growth signaling through Mad1 KD enhances the regrowth of both peripheral neurons and SCs to facilitate better regrowth of nerves. ANN NEUROL 2024
- 30 April 2024
- Published by Elsevier
- Vol. 201, 1-17
Hallmarks of peripheral nerve injury and regeneration
- 30 April 2024
- Published by Elsevier
- Vol. 201, 1-17
Hallmarks of peripheral nerve injury and regeneration